Mark S. Shearman
Impact in
- Physiology top 0.2%
- Alzheimer's disease research and treatments
- Pharmacology top 0.5%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Prion Diseases and Protein Misfolding 11
- Protein Kinase Regulation and GTPase Signaling 10
- Physiology 54
- Alzheimer's disease research and treatments 51
- Co-authors
- Dirk Beher (25 shared papers)Yasutomi Nishizuka (12 shared papers)Earl E. Clarke (16 shared papers)Alan Nadin (11 shared papers)Huw D. Lewis (20 shared papers)José L. Castro (10 shared papers)Stuart Hawtin (5 shared papers)Jonathan D.J. Wrigley (15 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (12 papers)Journal of Biological Chemistry (9 papers)Journal of Neurochemistry (6 papers)FEBS Letters (6 papers)Neurobiology of Aging (5 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Mark S. Shearman
95 papers receiving 5.9k citations
Mark S. Shearman's Hit Papers
Peers
Comparison fields: 5 of 111
- Physiology 3.2k
- Pharmacology 1.1k
- Cellular and Molecular Neuroscience 1.1k
- Molecular Biology 3.3k
- Computational Theory and Mathematics 759
Countries citing papers authored by Mark S. Shearman
This map shows the geographic impact of Mark S. Shearman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Shearman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Shearman more than expected).
Fields of papers citing papers by Mark S. Shearman
This network shows the impact of papers produced by Mark S. Shearman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Shearman. The network helps show where Mark S. Shearman may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark S. Shearman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 Hit paper breakdown → | 2000 | 737 |
| 2 | Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation Hit paper breakdown → | 1999 | 674 |
| 3 | 2000 | 311 | |
| 4 | 1995 | 192 | |
| 5 | 2001 | 175 | |
| 6 | 2003 | 166 | |
| 7 | 1989 | 163 | |
| 8 | 2004 | 143 | |
| 9 | 2009 | 143 | |
| 10 | 2001 | 133 | |
| 11 | 1987 | 122 | |
| 12 | 1987 | 116 | |
| 13 | 2007 | 111 | |
| 14 | 2001 | 105 | |
| 15 | 2005 | 99 | |
| 16 | 2013 | 93 | |
| 17 | 1995 | 91 | |
| 18 | 2005 | 78 | |
| 19 | 1995 | 77 | |
| 20 | 2005 | 76 |
About Mark S. Shearman
Mark S. Shearman is a scholar working on Molecular Biology, Physiology, Pharmacology, Cellular and Molecular Neuroscience and Oncology, having authored 96 papers that have together received 6.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (51 papers), Cholinesterase and Neurodegenerative Diseases (20 papers), Computational Drug Discovery Methods (14 papers), Drug Transport and Resistance Mechanisms (11 papers), Prion Diseases and Protein Misfolding (11 papers), Neuroscience and Neuropharmacology Research (10 papers), Protein Kinase Regulation and GTPase Signaling (10 papers) and Cellular transport and secretion (7 papers). The work is most often cited by research in Physiology (3.2k citations), Pharmacology (1.1k citations), Cellular and Molecular Neuroscience (1.1k citations), Molecular Biology (3.3k citations) and Computational Theory and Mathematics (759 citations). Mark S. Shearman has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Dirk Beher, Yasutomi Nishizuka, Earl E. Clarke, Alan Nadin, Huw D. Lewis, José L. Castro, Stuart Hawtin, Jonathan D.J. Wrigley, Adrian L. Smith and Ushio Kikkawa. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Journal of Neurochemistry, FEBS Letters and Neurobiology of Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.